Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey
Restricted accessResearch articleFirst published online October, 2021
Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey
The association between sarcopenia and protein intake has been well studied. However, limited data are available on the association between sarcopenia and protein intake in people with nonalcoholic fatty liver disease (NAFLD). This study aimed to investigate the association between protein intake and sarcopenia among elderly participants with NAFLD using the Korea National Health and Nutrition Examination Survey (KNHANES).
Methods:
Data of 4179 participants (1576 men and 2603 women, age ≥60 years) who participated in the KNHANES during 2008–2011 were obtained. Sarcopenia was defined as appendicular skeletal muscle mass/wt (%) of 1 standard deviation below the gender-specific mean for healthy adults and NAFLD as liver fat score using the fatty liver prediction models. According to their daily protein intake, participants were grouped into the high protein intake group (>1.2 g/kg/day), middle protein intake group (0.8–1.2 g/kg/day), and low protein intake group (<0.8 g/kg/day). Generalized linear models and logistic regression models were used.
Results:
The overall prevalence of sarcopenia in participants with NAFLD was 16.53%. Compared with the highest protein intake group, the low protein intake group had a significantly higher risk of sarcopenia (adjustment odds ratio = 1.707; 95% confidence interval = 1.009–2.886). In the fully adjusted model, the highest protein intake group had significantly lower levels of insulin, total body fat, vitamin B, and fat intake, whereas muscle proportions, energy, carbohydrates, vitamin A, and vitamin C intake of high protein intake participants were significantly higher than other groups.
Conclusion:
The prevalence of sarcopenia and sarcopenia-related factors were significantly lower in NAFLD elderly participants with high protein intake. These results suggest that high protein intake can help prevent and manage sarcopenia in people with NAFLD.
Get full access to this article
View all access options for this article.
References
1.
RossiAP, RubeleS, D'IntronoA, et al.An update on methods for sarcopenia diagnosis: From bench to bedside. Ital J Med, 2018; 12:97–107.
2.
GranicA, SayerAA, RobinsonSM. Dietary patterns, skeletal muscle health, and sarcopenia in older adults. Nutrients, 2019; 11:745.
3.
Cruz-JentoftAJ, LandiF, Topinková E, et al. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care, 2010; 13:1–7.
4.
LayG, ShivakumarC, GeoffreyC. Mechanisms and implications of age-related changes in the liver: Nonalcoholic fatty liver disease in the elderly. Curr Gerontol Geriatr Res, 2011; 2011:85136.
5.
EdithMK, SchoutenJN, HansenBE, et al.Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study. J Hepatol, 2012; 57:1305–1311.
6.
WijarnpreechaW, PanadeekarnP, AbyE, et al.Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity. Maturitas, 2019; 124:48–54.
7.
CleasbyME, JamiesonPM, AthertonPJ. Insulin resistance and sarcopenia: Mechanistic links between common co-morbidities. J Endocrinol, 2016; 229:R67–R81.
8.
PengT, WuL, ChenW, et al.Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition. Clin Nutr, 2019; 38:422–428.
9.
ChaputJP, LordC, CloutierM, et al.Relationship between antioxidant intakes and class I sarcopenia in elderly men and women. J Nutr Health Aging, 2007; 11:363–369.
10.
Paddon-JonesD, RasmussenBB. Dietary protein recommendations and the prevention of sarcopenia: Protein, amino acid metabolism and therapy. Curr Opin Clin Nutr Metab Care, 2009; 12:86.
11.
JamieIB, KimIY, WolfeRR. Protein consumption and the elderly: What is the optimal level of intake?. Nutrients, 2016; 8:359.
12.
HarrisLLS, SmithGI, PattersonBW, et al.Alterations in 3-hydroxyisobutyrate and FGF21 metabolism are associated with protein ingestion-induced insulin resistance. Diabetes, 2017; 66:1871–1878.
13.
RietmanA, SchwarzJ, Tomé D, et al. High dietary protein intake, reducing or eliciting insulin resistance?. Eur J Clin Nutr, 2014; 68:973.
14.
OhC, JeonBH, StormSNR, et al.The most effective factors to offset sarcopenia and obesity in the older Korean: Physical activity, vitamin D, and protein intake. Nutrition, 2017; 33:169–173.
15.
Ministry of Health and Welfare. Korea National Health and Nutrition Examination Survey Report (KNHANES IV) 2007–2009.
16.
Ministry of Health and Welfare. Korea National Health and Nutrition Examination Survey Report (KNHANES V) 2010–2012.
17.
MatthewsD, HoskerJ, RudenskiA, et al.Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412–419.
18.
OhK, LeeJ, LeeB, et al.Plan and Operation of the 4th Korea National Health and Nutrition Examination Survey (KNHANES IV). Korean J Epidemiol, 2007; 29:139–145.
19.
WillettW. Nutritional Epidemiology. Oxford University Press; 2012.
20.
OhC, NoJ. Appropriate protein intake is one strategy in the management of metabolic syndrome in Korean elderly to mitigate changes in body composition. Nutr Res, 2018; 51:21–28.
21.
Ministry of Health and Welfare. Dietary Reference Intakes for Koreans 2015. Sejong: Ministry of Health and Welfare; 2015.
22.
Montero-FernandezN, Serra-RexachJ. Role of exercise on sarcopenia in the elderly. Eur J Phys Rehabil Med, 2013; 49:131–143.
23.
HeymsfieldSB, SmithR, AuletM, et al.Appendicular skeletal muscle mass: Measurement by dual-photon absorptiometry. Am J Clin Nutr, 1990; 52:214–218.
24.
LimS, KimJH, YoonJW, et al.Sarcopenic obesity: Prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care, 2010; 33:1652–1654.
25.
GrundySM, CleemanJI, DanielsSR, et al.Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 2005; 112:2735–2752.
26.
AlbertiK, EckelRH, GrundySM, et al.Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 2009; 120:1640–1645.
27.
HaK, KimK, ChunOK, et al. Differential association of dietary carbohydrate intake with metabolic syndrome in the US and Korean adults: Data from the 2007–2012 NHANES and KNHANES. Eur J Clin Nutr 2018:72:848–860.
28.
KotronenA, PeltonenM, HakkarainenA, et al.Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology, 2009; 137:865–872.
29.
LeeYH, JungKS, KimSU, et al.Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011). J Hepatol, 2015; 63:486–493.
30.
PanX, HanY, ZouT, et al.Sarcopenia contributes to the progression of nonalcoholic fatty liver disease-related fibrosis: A meta-analysis. Dig Dis, 2018; 36:427–436.
31.
HongHC, HwangSY, ChoiHY, et al.Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology, 2014; 59:1772–1778.
32.
KalyaniRR, CorriereMLF. Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol, 2014; 2:819–829.
33.
ZhaiY, XiaoQ. The Common Mechanisms of Sarcopenia and NAFLD. Biomed Res Int, 2017; 2017:6297651.
34.
HelmrichSP, RaglandDR, LeungRW, et al.Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med, 1991; 325:147–152.
35.
BijlsmaA, MeskersC, van HeemstD, et al.Diagnostic criteria for sarcopenia relate differently to insulin resistance. Age, 2013; 35:2367–2375.
36.
Zelber-SagiS, Nitzan-KaluskiD, GoldsmithR, et al.Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol, 2007; 47:711–717.
37.
Paddon-JonesD, ShortKR, CampbellWW, et al.Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr, 2008; 87:1562S–1566S.
38.
Gaytán-GonzálezA, Ocampo-AlfaroMdJ, Torres-NaranjoF, et al.Dietary protein intake patterns and inadequate protein intake in older adults from four Countries. Nutrients, 2020; 12:3156.
39.
SymonsTB, SchutzlerSE, CockeTL, et al.Aging does not impair the anabolic response to a protein-rich meal. Am J Clin Nutr, 2007; 86:451–456.
40.
SaeedA, DullaartRP, SchreuderTC, et al.Disturbed vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD). Nutrients, 2018; 10:29.
41.
SantiagoE, RorizAK, RamosLB, et al.Comparison of calorie and nutrient intake among elderly with and without sarcopenia: A systematic review and meta-analysis. Nutr Rev, 2021; nuaa145https://doi.org/10.1093/nutrit/nuaa145.
42.
KaulmannA, BohnT. Carotenoids, inflammation, and oxidative stress—Implications of cellular signaling pathways and relation to chronic disease prevention. Nutr Res, 2014; 34:907–929.
43.
AbiriB, VafaM. Nutrition and sarcopenia: A review of the evidence of nutritional influences. Crit Rev Food Sci Nutr, 2019; 59:1456–1466.
44.
AkterS, DawsonJ, ChinS, et al.Associations among diet quality-related biomarkers, block food frequency questionnaire, and 24-hour dietary recall. Curr Dev Nutr, 2020; 4(Supplement_2):1374–1374.
